

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is i...
Q1 2027
Aug 10, 2026
Q2 2026
Sep 30, 2025
Q1 2026
Jul 18, 2025
FY 2025
Mar 31, 2025
Q4 2025
Mar 31, 2025